NexImmune, Inc. (NEXI) vs Trevena, Inc. (TRVN)
- NexImmune, Inc. NEXI 0.00 NaN
- Trevena, Inc. TRVN 0.00 −100.00%
NexImmune, Inc. and Trevena, Inc. are both Biotechnology companies. Trevena, Inc. is the larger, with a market value of $1.8M against $1.6M — 1.1× the size. NexImmune, Inc. has the higher net margin (0.00% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Trevena, Inc. leads on 6 and NexImmune, Inc. on 4.
Valuation
Profitability
| Metric | NEXI | TRVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | (190.29%) | 65.16% |
| Operating margin | 0.00% | (5,879.85%) | 0.00% |
| Net margin | 0.00% | (6,233.70%) | 0.00% |
| Free cash flow margin | 0.00% | (4,961.72%) | 0.00% |
| Return on equity | (232.97%) | 344.49% | (56.36%) |
| Return on assets | (140.56%) | (105.83%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack